Morningstar® Fund Report™

Overview
Chart
Performance
Risk and Rating
Portfolio
Management
Fees
Filings
Print 
PDF 
Methodology
Glossary 
Franklin Pharma Fund Growth
 
Performance History31/08/2011
Growth of 1,000 (INR)Advanced Graph
Performance History
Annual Returns31/08/2011
  200920102011
•Fund--114.137.0-5.7
•+/-Cat--15.64.2-
•+/-Idx--44.92.8-
 
Category: Sector - Healthcare
Index: S&P BSE Healthcare PR
 
 
Trailing Returns09/09/2011
 Fund +/-Idx
YTD-5.95 -18.17
3 Years Annualised27.53 12.94
5 Years Annualised17.02 -2.75
10 Years Annualised21.47 8.82
 
 
12 Month Yield 0.00
 
Key Stats
Morningstar Medalist Rating™
 
-
Morningstar® Category
Sector - Healthcare
Morningstar Rating™
Not Rated
ISIN
NAV   09/09/2011
INR 61.62
Day Change
-0.40%
Fund Size (mil)
31/08/2011
1,338.68 INR
Share Class Size (mil)
-
Total Expense Ratio
2.33%
Initial Charge
0.00%
Exit Charge
1.00%
Manager Name
Manager Start Date
Inception Date
31/03/1999
Exchange Name
-
 
Benchmark
 
Fund Benchmark
ET Pharma
Morningstar® Benchmark
S&P BSE Healthcare PR
 
Investment Objective
 
The Scheme aims to achieve long term capital appreciation through exclusively investing in Pharmaceutical/Life Sciences sector.
 
Portfolio Profile  -
Morningstar Style Box®
Equity Style
Large, Mid, SmallSize
Value, Blend, Growth
Style
 
 
Asset Allocation %
  % Long% ShortNet Assets
 
Top 5 Regions%
No Data Available
 
 
Top 5 Sectors%
No Data Available
 
 
Top 5 HoldingsSector%
No Data Available
Increase Decrease New since last portfolio